Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
life sciences
national blog main
clinical trials
eli lilly
fda
migraine
abbvie
allergan
american cancer society
avelumab
big pharma
biohaven
biovex
boehringer ingelheim
breast cancer
calcitonin gene-related peptide
cancer
cgpr
checkpoint inhibitor
chemotherapy
chronic migraine
city hill ventures
delos capital
drugs
episodic migraine
erasca
europe blog main
imlygic
immunotherapy
indiana
indiana blog main
indiana top stories
jonathan lim
matt coffey
merck
merck kgaa
national
national cancer institute
What
approved
3
×
class
fda
medicines
migraine
new
adults
allergan
announced
approval
bio
cancer
combo
companies
dating
decision
developed
drug
eli
game
happening
headache
immunotherapies
kgaa
late
lilly
marks
medications
merck
monday
nod
oncolytics
pain
pfizer
pharmaceutical
pill
prevent
sorts
speed
starts
Language
unset
Current search:
amgen
×
approved
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
